Nikkei 225

M3

M3 provides online platforms for doctors and medical marketing services as a healthcare IT firm. Nikkei 225 constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.

2413.T Updated Jul 11, 2026 2 AI consumers· 1 recurring

Annual return · 2026-07-10'21-50.6%'22-19.1%'23-32.5%'24-39.1%'25+36.2%YTD-0.8%
Money in·
M3~¥260B
Money out·

Financials & Segments

  • Total revenue · ~¥260B (FY2024)
  • Segments · Medical platform · Clinical trial solutions · Career and overseas business

Revenue from

No refined links yet.

Pays to

No refined links yet.


← All companiesMarkdown · JSON

For information only, not investment advice. Content on this site is generated by AI from verified, cross-checked sources and may contain errors.

© 2026 Willow Investments, Inc.Company value-chain data · contact@willowinvt.com